Skip Navigation


NDT Advance Access originally published online on September 22, 2008
Nephrology Dialysis Transplantation 2008 23(12):3746-3748; doi:10.1093/ndt/gfn532
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/12/3746    most recent
gfn532v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Murtagh, F. E. M.
Right arrow Articles by Sheerin, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murtagh, F. E. M.
Right arrow Articles by Sheerin, N. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Illness trajectories: an important concept in the management of kidney failure

Fliss E. M. Murtagh1, Emma Murphy2 and Neil S. Sheerin3

1 Department of Palliative Care, Policy & Rehabilitation, King's College London, London SE5 9RJ 2 Renal Unit, Guy's and St Thomas’ NHS Foundation Trust, London SE1 9RT 3 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK

Correspondence and offprint requests to: Neil Sheerin, Institute of Cellular Medicine, 4th Floor, William Leech Building, Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK. Tel: +44-191-222-7146; Fax: +44-191-222-0723; E-mail: neil.sheerin@ncl.ac.uk

Keywords: disease trajectory; end of life care; stage 5 chronic kidney disease

The first 10% of the full text of this article appears below.



   Introduction
 
The number of patients diagnosed with chronic kidney disease (CKD) is increasing, with recent studies suggesting that >10% of the population may have CKD [1,2]. This high prevalence is due to a variety of factors. A major contributor, in developed countries, is the increasing age of the population; epidemiological studies show that the prevalence of CKD increases dramatically with advancing age [2]. As the population lives longer and the proportion of older people increases, so the prevalence of CKD increases. In addition, use of estimated glomerular filtration rate (eGFR) has contributed to increased recognition of CKD [3]. Improved accessibility to renal services has also meant that many patients previously not referred are now being seen by nephrologists.

The presence of CKD has many implications for the patients, including increased morbidity . . . [Full Text of this Article]



   Disease trajectories
 


   Implications of disease trajectories
 


   Trajectories in renal disease
 


   Summary
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?